Status:
UNKNOWN
Coblation in Endoscopic Sinus Surgery
Lead Sponsor:
Western University, Canada
Conditions:
Blood Loss
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Chronic Rhinosinusitis (CRS) refers to a pathological condition where the sinonasal mucosa is inflamed for greater than 12 weeks(1). It is associated with a constellation of symptoms, including facial...
Eligibility Criteria
Inclusion
- between 18-70 years old, and
- having a diagnosis of CRS.
Exclusion
- previous Endoscopic Sinus Surgery,
- coagulopathies,
- being pregnant, or
- being prescribed anti-coagulants or anti-platelet agents
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01793987
Start Date
May 1 2013
End Date
May 1 2014
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Health Care
London, Ontario, Canada, N6A 4V2